These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 3437612)

  • 1. Serum levels of maprotiline and its adverse effects on depressed patients.
    Kurata K; Kido H; Hasegawa M; Inoue M; Yamaguchi N
    Jpn J Psychiatry Neurol; 1987 Jun; 41(2):247-54. PubMed ID: 3437612
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparison of maprotiline and its desmethylated metabolite serum concentrations in outpatients and inpatients.
    Kurata K; Kido H; Hasegawa M; Inoue M; Yamaguchi N
    Jpn J Psychiatry Neurol; 1987 Jun; 41(2):255-60. PubMed ID: 3437613
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationship between blood concentrations and clinical effects of a new antidepressant "maprotiline".
    Watanabe S; Yokoyama S; Kubo S; Iwai H; Kuyama C
    Folia Psychiatr Neurol Jpn; 1980; 34(2):147-56. PubMed ID: 7007180
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Blood concentrations of maprotiline in depressive patients].
    Rouillon F; Sioufi A; Serrurier D; Mizon JP; Plaquet R; Richard JB; Riche C; Bourin M; Kergueris MF; Besançon G
    Encephale; 1988; 14(4):299-305. PubMed ID: 3058453
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma levels of maprotiline and zimelidine and their relationship to clinical response in depressed patients.
    Hrdina PD; Lapierre YD
    Ther Drug Monit; 1986; 8(4):400-6. PubMed ID: 2950616
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oxaprotiline in the treatment of endogenous depressed inpatients an early clinical trial.
    Schmauss M; Laakmann G; Dieterle D; Blaschke D
    Pharmacopsychiatry; 1985 Jul; 18(4):282-5. PubMed ID: 3895255
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Complex visual disturbances during maprotiline treatment.
    Yoshino T; Nisijima K; Shioda K; Kato S
    Psychiatry Clin Neurosci; 2012 Oct; 66(6):533-4. PubMed ID: 23066771
    [No Abstract]   [Full Text] [Related]  

  • 8. Cross-over trial comparing the antidepressant effects of amineptine and maprotiline.
    Bornstein S
    Curr Med Res Opin; 1979; 6(2):107-10. PubMed ID: 380910
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatitis caused by antidepressive therapy with maprotiline and opipramol.
    Braun JS; Geiger R; Wehner H; Schäffer S; Berger M
    Pharmacopsychiatry; 1998 Jul; 31(4):152-5. PubMed ID: 9754852
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incidence of seizures with tricyclic and tetracyclic antidepressants.
    Jabbari B; Bryan GE; Marsh EE; Gunderson CH
    Arch Neurol; 1985 May; 42(5):480-1. PubMed ID: 3994566
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Seizures associated with high maprotiline serum concentrations.
    Molnar G
    Can J Psychiatry; 1983 Nov; 28(7):555-6. PubMed ID: 6418369
    [TBL] [Abstract][Full Text] [Related]  

  • 12. GLC-mass spectrometric determination of maprotiline and its major metabolite using stable isotope-labeled analog as internal standard.
    Jindal SP; Lutz T; Vestergaard P
    J Pharm Sci; 1980 Jun; 69(6):684-7. PubMed ID: 7205583
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Non-response to maprotiline caused by ultra-rapid metabolism that is different from CYP2D6?
    Vormfelde SV; Bitsch A; Meineke I; Gundert-Remy UM; Gleiter CH
    Eur J Clin Pharmacol; 1997; 52(5):387-90. PubMed ID: 9272409
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Response to maprotiline treatment in depressive patients relationship to urinary MHPG excretion and plasma drug level.
    Gaertner HJ; Golfinopoulos G; Breyer-Pfaff U
    Pharmacopsychiatria; 1982 Sep; 15(5):170-4. PubMed ID: 7178231
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy, side-effects, plasma and blood levels of maprotiline (Ludiomil).
    Miller PI; Beaumont G; Seldrup J; John V; Luscombe DK; Jones R
    J Int Med Res; 1977; 5 Suppl 4():101-11. PubMed ID: 590605
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Depression in the elderly: pharmacologic considerations in treatment.
    Veith RC
    J Am Geriatr Soc; 1982 Sep; 30(9):581-6. PubMed ID: 6125536
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chemistry, pharmacology, pharmacokinetics, adverse effects, and efficacy of the antidepressant maprotiline hydrochloride.
    Wells BG; Gelenberg AJ
    Pharmacotherapy; 1981; 1(2):121-39. PubMed ID: 6765485
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recognizing and treating depressed patients with maprotiline.
    Lerfald SC
    Md State Med J; 1982 Nov; 31(11):44-7. PubMed ID: 7176695
    [No Abstract]   [Full Text] [Related]  

  • 19. Quantitative high-performance liquid chromatographic assay for the determination of maprotiline and oxaprotiline in human plasma.
    Kuss HJ; Feistenauer E
    J Chromatogr; 1981 Jan; 204():349-53. PubMed ID: 7217264
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Maprotiline in affective illness. Plasma concentration and clinical response.
    Norman TR; Burrows GD; Maguire KP; McIntyre IM; Scoggins BA
    J Affect Disord; 1983 May; 5(2):147-54. PubMed ID: 6222094
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.